Intestinal stem cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for ...

Genetically or pharmaceutically eradicating aging cells in the brain may improve memory and reduce seizures in temporal lobe ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

A combination of two classical biological laws, the global constraint principle delves deeper into complex biological ...

T his past year, we explored a lot of new cell biology research—from cancer to plants to microbes, and more! It’s hard to ...

Specifically, the team confirmed that increased expression of cytoskeleton-binding and actin-binding proteins leads to a stable restructuring of the internal cellular architecture. This provides the ...

The drug is called NU-9, and a team from Northwestern University in the US tested it on mouse models of Alzheimer's disease.

Temporal lobe epilepsy, which results in recurring seizures and cognitive dysfunction, is associated with premature aging of ...

Scientists have traced a devastating pattern of brain cell loss in a handful of families to a single, ultra-rare mutation ...

Ulsan National Institute of Science and Technology (UNIST) announced on the 23rd that a team led by Professor Sung-Deuk Choi ...

SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) on December 10 for gastric cancer (including gastroesophageal junction cancer) to SNB-101 (API ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...